WebJul 7, 2014 · Cisplatin (cis-[PtCl2(NH3)2]), carboplatin ([Pt(O,O'-cdbca)(NH3)2], cbdca = cyclobutane-1,1-dicarboxylate) and oxaliplatin ([Pt(R,R-cyclohexane-1,2-diamine)(O,O′-ethanedioato)]) are used in combination with other agents to treat a range of malignancies including testicular, ovarian, head and neck, bladder, esophageal, and small cell lung … WebResults: Cisplatin-induced neuropathy was more similar to neuropathy in patients receiving oxaliplatin than in those receiving paclitaxel. The cisplatin and oxaliplatin groups exhibited the coasting phenomenon and more prominent upper extremity symptoms than lower extremity symptoms during chemotherapy administration weeks.
Platinum-Based Chemotherapy: Uses, Effectiveness, Side …
WebMay 20, 2010 · Oxaliplatin [ [ (1 R ,2 R )-cyclohexane-1,2-diamine] (ethanedioate- O, 𝑂 )platinum (II)] is a third-generation platinum compound widely used for the treatment of metastatic colorectal cancer and a variety of other malignancies, such as breast cancer, melanoma, non-Hodgkin lymphoma, and head and neck cancer [ 23 – 25 ]. WebAs compared with cisplatin, oxaliplatin was associated with significantly less grade 3 or 4 neutropenia and alopecia but significantly more grade 3 or 4 diarrhea and peripheral neuropathy. Grade... flying fish studio
Cisplatin in cancer therapy: molecular mechanisms of action
WebHowever, the RUNX1 (rs2014300) genotypes were not significantly associated with the OS of patients who received chemotherapy based on cisplatin or oxaliplatin in the dominant models. Therefore, these results demonstrated that 2R/3R and 2R/2R were hazards for patients’ prognosis involving adjuvant chemotherapy based on cisplatin (CDDP). WebMar 3, 2024 · Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell ... WebAug 5, 2015 · Abstract. Oxaliplatin was the first platinum drug with proven activity against colorectal tumors, becoming a standard in the management of this malignancy. It is also considered for the treatment of pancreatic and gastric cancers. However, a major reason for treatment failure still is the existence of tumor intrinsic or acquired resistance. … green line down iphone